Jonathan Menkes Comments on Sports Trademark Trends and Generative AI in World Intellectual Property Review
In a recent interview with World Intellectual Property Review, Knobbe Martens Trademark and Brand Protection partner Jonathan Menkes, Co-Chair of the firm’s Sports and Gaming practice, shared insights on the...
FDA Issues Recommendations for the Development of Individualized Therapies for Patients With Ultra-Rare Diseases
Key Takeaway: The FDA is developing a “plausible mechanism framework” to facilitate approval of individualized therapies for the treatment of rare genetic diseases that currently face approval challenges. As discussed previously...
Federal Circuit Confirms Patent Eligibility of Gene Therapy Patent in Regenexbio Inc. v. Sarepta Therapeutics
Key Takeaway: Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature. In REGENXBIO Inc. v....